sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global Hemostats Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

Global Hemostats Market Analysis, Companies Profiles, Size, Share, Growth, Trends...

Home / Categories / Healthcare
Global Hemostats Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
Global Hemostats Market Analysis, Companies...
Report Code
RO1/110/1368

Publish Date
01/May/2017

Pages
278
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Table Of Contents ;
1. Introduction

1.1. Objectives Of The Study
1.2. Market Definition
1.3. Overview Of Global Hemostats Market
1.4. Currency And Pricing
1.5. Limitation
1.6. Markets Covered

2. Market Segmentation

2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered For The Study
2.4. Currency And Pricing
2.5. Research Methodology
2.6. Primary Interviews With Key Opinion Leaders
2.7. Secondary Source
2.8. Assumptions

3. Market Overview

3.1. Drivers

3.1.1. Chronic Conditions And Aging Population Leading To Increase In Number Of Surgical Procedures
3.1.2. Technological Advancements
3.1.3. Increasing Number Of Minimally Invasive Surgeries
3.1.4. Improving Healthcare Infrastructure And Increasing Healthcare Spending

3.2. Restraints

3.2.1. Reluctance Of Surgeons Towards New Products
3.2.2. Weak Reimbursement

3.3. Opportunities

3.3.1. Unmet Medical Needs
3.3.2. Emerging Market

3.4. Challenges

3.4.1. Development Of Substitute Products
3.4.2. Limitations Of Hemostatic Agents In Achieving Hemostasis

4. Premium Insights

5. Regulatory

5.1. Overview
5.2. Regulatory Procedure

6. Reimbursement

6.1. Overview
6.2. Reimbursement Scenario

7. Executive Summary

8. Global Hemostats Market, By Type

8.1. Overview
8.2. Thrombin Based Hemostats
8.3. Combination Agent Hemostats
8.4. Oxidized Regenerated Cellulose Based Hemostats
8.5. Gelatin Based Hemostats
8.6. Collagen Based Hemostats

9. Global Hemostats Market,By Application

9.1. Overview
9.2. Global Hemostats Market, By Application
9.3. Wound Closure
9.4. Surgical Hemostats

10. Global Hemostats Market, By Distribution Channel

10.1. Overview
10.1.1. Direct Tenders
10.1.2. Retail

11. Global Hemostats Market, By End User

11.1. Overview
11.2. Hospitals
11.3. Ambulatory Centers
11.4. Community Healthcare
11.5. Clinics

12. Global Hemostats Market, By Geography

12.1. Overview

12.2. North America

12.2.1. U.S.
12.2.2. Canada
12.2.3. Mexico

12.3. Europe

12.3.1. Germany
12.3.2. France
12.3.3. U.K.
12.3.4. Italy
12.3.5. Spain
12.3.6. Russia
12.3.7. Turkey
12.3.8. Belgium
12.3.9. Netherlands
12.3.10. Switzerland
12.3.11. Rest Of Europe

12.4. Asia-Pacific (Asia-Pacific)

12.4.1. Japan
12.4.2. China
12.4.3. South Korea
12.4.4. India
12.4.5. Australia
12.4.6. Singapore
12.4.7. Thailand
12.4.8. Malaysia
12.4.9. Indonesia
12.4.10. Philippines
12.4.11. Rest Of Asia-Pacific

12.5. South America

12.5.1. Brazil
12.5.2. Rest Of South America

12.6. Mea

12.6.1. South Africa
12.6.2. Rest Of Mea

13. Global Hemostats Market, Company Landscape

13.1. Company Share Analysis; Global
13.2. Company Share Analysis; North America
13.3. Company Share Analysis; Europe
13.4. Company Share Analysis; Asia-Pacific

14. Company Profiles

14.1. Ethicon Us, Llc (Subsidiary Of Johnson & Johnson Services, Inc)

14.1.1. Company Overview
14.1.2. Revenue Analysis
14.1.3. Product Portfolio
14.1.4. Recent Developments

14.2. Pfizer

14.2.1. Company Overview
14.2.2. Revenue Analysis
14.2.3. Product Portfolio
14.2.4. Recent Developments

14.3. C.R Bard

14.3.1. Company Overview
14.3.2. Revenue Analysis
14.3.3. Product Portfolio
14.3.4. Recent Developments

14.4. Baxter

14.4.1. Company Overview
14.4.2. Revenue Analysis
14.4.3. Product Portfolio
14.4.4. Recent Developments

14.5. Vascular Solutions, Inc (Acquired By Teleflex Incorporated)

14.5.1. Company Overview
14.5.2. Revenue Analysis
14.5.3. Product Portfolio
14.5.4. Recent Developments

14.6. B.Braun Melsungen Ag

14.6.1. Company Overview
14.6.2. Revenue Analysis
14.6.3. Product Portfolio
14.6.4. Recent Developments

14.7. 3-D Matrix Ltd

14.7.1. Company Overview
14.7.2. Revenue Analysis
14.7.3. Product Portfolio
14.7.4. Recent Developments

14.8. Resorba Medical Gmbh

14.8.1. Company Overview
14.8.2. Revenue Analysis
14.8.3. Product Portfolio
14.8.4. Recent Developments

14.9. Anika Therapeutics, Inc.

14.9.1. Company Overview
14.9.2. Revenue Analysis
14.9.3. Product Portfolio
14.9.4. Recent Developments

14.10. Biom?Up

14.10.1. Company Overview
14.10.2. Revenue Analysis
14.10.3. Product Portfolio
14.10.4. Recent Developments

14.11. Cryolife, Inc.

14.11.1. Company Overview
14.11.2. Revenue Analysis
14.11.3. Product Portfolio
14.11.4. Recent Developments

14.12. Equimedical

14.12.1. Company Overview
14.12.2. Revenue Analysis
14.12.3. Product Portfolio
14.12.4. Recent Developments

14.13. Hemostasis, Llc

14.13.1. Company Overview
14.13.2. Revenue Analysis
14.13.3. Product Portfolio
14.13.4. Recent Developments

14.14. Medtrade Products Limited

14.14.1. Company Overview
14.14.2. Revenue Analysis
14.14.3. Product Portfolio
14.14.4. Recent Developments

14.15. Stryker

14.15.1. Company Overview
14.15.2. Revenue Analysis
14.15.3. Product Portfolio
14.15.4. Recent Developments

14.16. Arch Therapeutics, Inc.

14.16.1. Company Overview
14.16.2. Revenue Analysis
14.16.3. Product Portfolio
14.16.4. Recent Developments

14.17. Integra Lifesciences Corporation

14.17.1. Company Overview
14.17.2. Revenue Analysis
14.17.3. Product Portfolio
14.17.4. Recent Developments

14.18. Altaylar Medical

14.18.1. Company Overview
14.18.2. Revenue Analysis
14.18.3. Product Portfolio
14.18.4. Recent Developments

14.19. Biocer Entwicklungs-Gmbh

14.19.1. Company Overview
14.19.2. Revenue Analysis
14.19.3. Product Portfolio
14.19.4. Recent Developments

14.20. Smi (Starch Medical)

14.20.1. Company Overview
14.20.2. Revenue Analysis
14.20.3. Product Portfolio
14.20.4. Recent Developments

15. Related Reports

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com